Search: onr:"swepub:oai:prod.swepub.kib.ki.se:138156725" >
ERF deletion rescue...
ERF deletion rescues RAS deficiency in mouse embryonic stem cells
-
Mayor-Ruiz, C (author)
-
Olbrich, T (author)
-
Drosten, M (author)
-
show more...
-
Lecona, E (author)
-
Vega-Sendino, M (author)
-
Ortega, S (author)
-
Dominguez, O (author)
-
Barbacid, M (author)
-
Ruiz, S (author)
-
- Fernandez-Capetillo, O (author)
- Karolinska Institutet
-
show less...
-
(creator_code:org_t)
- 2018-04-12
- 2018
- English.
-
In: Genes & development. - : Cold Spring Harbor Laboratory. - 1549-5477 .- 0890-9369. ; 32:7-8, s. 568-576
- Related links:
-
http://genesdev.cshl...
-
show more...
-
http://kipublication...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- MEK inhibition in combination with a glycogen synthase kinase-3β (GSK3β) inhibitor, referred as the 2i condition, favors pluripotency in embryonic stem cells (ESCs). However, the mechanisms by which the 2i condition limits ESC differentiation and whether RAS proteins are involved in this phenomenon remain poorly understood. Here we show that RAS nullyzygosity reduces the growth of mouse ESCs (mESCs) and prohibits their differentiation. Upon RAS deficiency or MEK inhibition, ERF (E twenty-six 2 [Ets2]-repressive factor), a transcriptional repressor from the ETS domain family, translocates to the nucleus, where it binds to the enhancers of pluripotency factors and key RAS targets. Remarkably, deletion of Erf rescues the proliferative defects of RAS-devoid mESCs and restores their capacity to differentiate. Furthermore, we show that Erf loss enables the development of RAS nullyzygous teratomas. In summary, this work reveals an essential role for RAS proteins in pluripotency and identifies ERF as a key mediator of the response to RAS/MEK/ERK inhibition in mESCs.
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database